Iris disorder
diseaseOn this page
Also known as disease of irisdisease or disorder of irisdisorder of irisiris diseaseiris disease or disorder
Summary
Iris disorder (MONDO:0002289) is a disease (an umbrella term covering 8 Mondo subtypes) with 2 GWAS associations across 5 studies and 3 clinical trials. A subtype of uveal disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Umbrella term: 8 Mondo subtypes
- GWAS associations: 2
- Clinical trials: 3
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | iris disorder |
| Mondo ID | MONDO:0002289 |
| MeSH | D007499 |
| DOID | DOID:240 |
| NCIT | C34737 |
| SNOMED CT | 85478004 |
| UMLS | C0022078 |
| MedGen | 9556 |
| Anatomy (UBERON) | UBERON:0001769 |
| Is cancer (heuristic) | no |
Also known as: disease of iris · disease or disorder of iris · disorder of iris · iris disease · iris disease or disorder · iris disorder
Data availability: 2 GWAS associations (5 studies).
Disease family
This is a subtype of uveal disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › disorder of orbital region › eye disorder › uveal disorder › iris disorder
Related subtypes (3): optic choroid disorder, uveitis, uvea neoplasm
Subtypes (8): pupil disorder, ciliary body disorder, iritis, exfoliation syndrome, aniridia, iris neoplasm, anterior segment dysgenesis 3, intraoperative floppy iris syndrome
Genetics & variants
GWAS landscape
2 GWAS associations across 5 studies. Top hits map to 1 distinct genes (as reported by GWAS).
Top associations by p-value
| rsID | p-value | Gene | Risk allele | Odds ratio |
|---|---|---|---|---|
| rs1042602 | 2e-12 | TYR | C | 0.15 |
Top studies (by case count)
| Study | Lead author | Year | Cases | Controls | Title |
|---|---|---|---|---|---|
| GCST90475899 | Verma A | 2024 | 4,472 | 441,070 | Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. |
| GCST90477786 | Verma A | 2024 | 1,118 | 119,290 | Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. |
| GCST90480100 | Verma A | 2024 | 1,118 | 119,290 | Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. |
| GCST90481942 | Verma A | 2024 | 463 | 58,885 | Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. |
| GCST90436026 | Zhou W | 2018 | 405 | 401,245 | Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies. |
Variant details and genetic-evidence tiers
Tier distribution (top 50 variants)
| Tier | Variants |
|---|---|
| Tier 1: coding | 1 |
| Tier 2: splice/UTR | 0 |
| Tier 3: regulatory | 0 |
| Tier 4: intronic/intergenic | 0 |
MAF distribution
| Bucket | Variants |
|---|---|
| common (>=0.05) | 1 |
| low_freq (0.01-0.05) | 0 |
| rare (<0.01) | 0 |
| unknown | 0 |
Functional consequences
| Consequence | Count |
|---|---|
| missense_variant | 1 |
Top variants
| rsID | Chr | Pos | Alleles | MAF | Consequence | Gene | p-value | Tier |
|---|---|---|---|---|---|---|---|---|
| rs1042602 | 11 | 89178528 | C>A | 0.371 | missense_variant | TYR | 2e-12 | Tier 1: coding |
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 3.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| Not specified | 3 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT04011878 | Not specified | COMPLETED | Histopathological Examination of Iris Tissue in Buphthalmos |
| NCT05759715 | Not specified | COMPLETED | Iris Color and Day-Night Changes in the Sympathovagal Ratio |
| NCT07034651 | Not specified | COMPLETED | Electron Microscopic Examination of Iris Tissue in Buphthalmos |
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.